Advancing Participatory Arts Health in Dutch Care Systems

By João L. Carapinha

March 30, 2026

participatory arts health

Participatory arts health is gaining recognition as a valuable complement to traditional medical care, supporting both physical and psychosocial well-being for people living with chronic conditions and those at the end of life.

In this article we explore how creative, participatory approaches can help patients express emotions, build resilience, and improve quality of life where medication alone often falls short.

Healing Through Creative Connection

Professor Tineke Abma highlights the power of participatory arts health initiatives — from dance for people with Parkinson’s disease to music therapy for dementia and bedside singing for the terminally ill. These collaborative artistic activities enable patients to better manage the emotional and physical burdens of serious illness.

Strong Evidence from Three Decades of Research

Scientific studies into the healing effects of the arts spans nearly thirty years. Clinical studies suggest that the arts deliver measurable benefits for physical and mental health while strengthening resilience. Evidence is now particularly strong for dance in Parkinson’s and music in dementia care.

From Hospital to Home: Real-World Integration

Dutch care organisations are increasingly embedding participatory arts health into everyday practice. Cordaan’s ambulant arts team, for example, sends artists into the homes of older adults experiencing loneliness or existential distress. This approach not only meets important psychosocial needs but also reduces pressure on scarce district nursing resources.

Preserving Artistic Freedom While Proving Value

While the evidence base continues to grow, questions remain around cost-effectiveness and sustainable reimbursement. Payers will require well-designed studies that capture the unique benefits of these interventions without over-medicalising them through rigid protocols. The collaboration between Cordaan, Erasmus University, and the Museum of the Mind aims to generate the high-quality evidence needed to support broader adoption of participatory arts health across Dutch long-term care.

Reference url

Recent Posts

cemdisiran gMG treatment
Breakthrough in cemdisiran gMG treatment Advances Regulatory Landscape

By João L. Carapinha

June 25, 2026

Cemdisiran gMG treatment has cleared a critical hurdle after the FDA and EMA accepted Regeneron’s regulatory submissions for review in anti-AChR antibody-positive generalized myasthenia gravis (gMG). The investigational siRNA therapy targeting complement protein C5 could become the first subcutan...
Trodelvy ADC approval
Advancements in Breast Cancer Treatment Following Trodelvy ADC Approval

By João L. Carapinha

June 25, 2026

The Trodelvy ADC approval by the European Commission delivers the first antibody-drug conjugate approved for first-line use in adults with unresectable or metastatic triple-negative breast cancer who are ineligible for PD-1 or PD-L1 inhibitors. This
Cemiplimab Cervical Cancer Access
Cemiplimab Cervical Cancer Access Navigating Treatment and Value

By João L. Carapinha

June 24, 2026

Cemiplimab Cervical Cancer Access has been endorsed by NICE for adults with recurrent or metastatic cervical cancer that has progressed after platinum-based chemotherapy, provided patients have not previously received immunotherapy. The final draft guidance confirms that this PD-1 inhibitor deliv...